Immune Cell Therapy
Focus on immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment.
R&D of New Drugs and Clinical Trial
Develop new anti-cancer drugs and actively seeking new collaboration opportunities.
Diagnosis of Infectious Diseases
Develop diagnostic tools for detecting infectious diseases.
E-Commerce
Develop a strong e-commerce platform for sales of pharmaceutical,healthcare and cosmetic products.
World's Leading Enterprise in
Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA, with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.
Beroni Group’s overall strategic goal is to become a world’s leading enterprise in the biotechnology, life sciences, and environmental science industries.
4
Countries in operation
200+
Research scientists
17
Award nominations
50k+
product types
Beroni Australia
Suite 401, 447 Kent Street,
Sydney, NSW 2000
Australia
- +61 2 8051 3055
Beroni China
Level 10/ Building 11
Zhong Bei High Technology Industry Park
XiQing District, Tianjin
China
- +86 22 5995 5753
Beroni Japan
1 – 144#6 Ginza, Tyuo-ku
Tokyo 104-0061
Japan
- +81 3 3863 8998
Dendrix Inc.
4F, Closepoint Building
3-29-1, Ebisu
Shibya-ku, Tokyo
Japan
- +81 3 5475 6411
Medicine Plus
8F, Chiyoda Building East
2-9-4 Higashi Tenman Kita-ku
Osaka-shi, Osaka
Japan
- +81 6 6358 8151
Beroni USA
2083 Center Avenue #3A
Fort Lee
New Jersey 07024
United State of America
- +1 214 762 2888
